Enjoy SmartLeges Premium!

Subscribe to SmartLeges Premium and enjoy the following advantages:

  • Consult as many laws as you need with no additional charge
  • Consult almost any law in several countries with the new advanced search engine. All legislation within reach!
  • Enjoy all SmartLeges functions without restrictions
See the plans

An essential and free application for professionals and students in the legal sector

Read more
 

Sign up for free!

Would you like to consult this and other laws complete?

Sign up for free to consult all the laws of SmartLeges in your mobile phone or tablet, as well as underline text, add notes...

Sign up for free!

Email Facebook Twitter Google Linkedin Tumblr

THE MISUSE OF DRUGS (AMENDMENT) REGULATIONS (NORTHERN IRELAND) 2013

Northern Ireland Statutory Rules

Version as made

2013 No. 78


  • Version as made

Introductory Text

Statutory Rules of Northern Ireland

2013 No. 78

Dangerous Drugs

The Misuse of Drugs (Amendment) Regulations (Northern Ireland) 2013

Made

21st March 2013

Coming into operation

10th April 2013

The Department of Health, Social Services and Public Safety makes the following Regulations in exercise of the powers conferred by sections 7, 10, 22 and 31 of the Misuse of Drugs Act 1971(1) as adapted by section 38 of that Act and now vested in it(2) and after consultation with the Advisory Council on the Misuse of Drugs in accordance with section 31(3) of that Act.

Citation, commencement and interpretation

1.  (1)   These Regulations may be cited as the Misuse of Drugs (Amendment) Regulations (Northern Ireland) 2013 and shall come into operation on 10th April 2013.

(2)  In these Regulations the “2002 Regulations” means the Misuse of Drugs Regulations (Northern Ireland) 2002(3 )
(3)  The Interpretation Act (Northern Ireland) 1954(4 ) shall apply to these Regulations as it applies to an Act of the Assembly.

Amendment of the Misuse of Drugs Regulations (Northern Ireland) 2002

2.  The 2002 Regulations are amended as provided by regulations 3 to 6.

Amendment of regulation 22

3.  After regulation 22(4) insert—

“(5)   Every person who is authorised by or under any provision of the Act to have in his possession or to destroy, or cause to be destroyed, the substance specified in paragraph 5 of Part I of Schedule 4 shall make a record of each quantity of such drug possessed or destroyed.
(6)   Paragraph (5) shall not have effect in relation to—
(a) a patient to whom the substance specified in paragraph 5 of Part I of Schedule 4 has been prescribed;
(b) a constable when acting in the course of his duty as such;
(c) a person engaged in the business of a carrier when acting in the course of that business;
(d) a person engaged in the business of a postal operator (within the meaning of Part 3 of the Postal Services Act 2011) (5 ) when acting in the course of that business;
(e) an officer of customs and excise when acting in the course of his duty as such;
(f) a person engaged in the work of any laboratory to which the substance specified in paragraph 5 of Part I of Schedule 4 has been sent for forensic examination when acting in the course of his duty as a person so engaged; and
(g) a person engaged in conveying the substance specified in paragraph 5 of Part I of Schedule 4 to a person who may lawfully have that substance in his possession.”.

Amendment of regulation 27

4.  In regulation 27(5) (destruction of controlled drugs) for “regulation 22(2) or (3) or 24(3) ” substitute “regulation 22(2) , (3) or (5) or 24(3) ”.

Amendment of Schedule 1

5.  In paragraph 1(a) of Schedule 1 (controlled drugs subject to the requirements of regulations 14, 15, 16, 18, 19, 20, 23, 26 and 27) after “Cannabis” insert “(not being the substance specified in paragraph 5 of Part I of Schedule 4) ”.

Amendment of Schedule 4

6.  After paragraph 4 of Part I of Schedule 4 (controlled drugs subject to the requirements of regulations 22, 23, 26 and 27) insert— “5.   A liquid formulation—
(a) containing a botanical extract of cannabis—
(i) with a concentration of not more than 30 milligrams of cannabidiol per millilitre, and not more than 30 milligrams of delta-9-tetrahydrocannabinol per millilitre, and
(ii) where the ratio of cannabidiol to delta-9-tetrahydrocannabinol is between 0.7 and 1.3,
(b) which is dispensed through a metered dose pump as a mucosal mouth spray, and
(c) which was approved for marketing by the Medicines and Healthcare products Regulatory Agency on 16 th June 2010(6 ) ”. Sealed with the Official Seal of the Department of Health, Social Services and Public Safety on 21st March 2013 Legal seal Linda DevlinA senior officer of theDepartment of Health, Social Services and Public Safety
EXPLANATORY NOTE(This note is not part of the Regulations) These Regulations amend the Misuse of Drugs Regulations (Northern Ireland) 2002 to provide, in regulations 5 and 6, for the cannabis-based medicine “Sativex” to be placed in Part I of Schedule 4 to the Misuse of Drugs Regulations (Northern Ireland) 2002. Regulation 3 inserts new paragraph (5) into regulation 22 which provides that a person, other than those persons specified in new paragraph (6) , who is authorised to possess or to destroy, or cause to be destroyed, “Sativex” shall make a record of the quantity possessed or destroyed, and regulation 4 excepts a person who makes such a record under new regulation 22(5) from the requirements relating to the destruction of controlled drugs contained in regulation 27(1) or (3) of the Misuse of Drugs Regulations (Northern Ireland) 2002. A full impact assessment of the effect that this instrument will have on the costs of business and the voluntary sector is available and is published with the Explanatory Memorandum alongside the instrument on www.legislation.gov.uk/ . (1) 1971 c.38 Section 22 of that Act was amended by section 177(1) of, and paragraph 12 of Schedule 4 to, the Customs and Excise Management Act 1979(c.2) (2) S.R. & O.(N.I) 1973 No. 504 ; Article 5(a) and S.I.1999/283(N.I.1) , Article 3(6) (3) S.R 2002 No. 1 (4) 1954 c.33 (N.I) (5) 2011 c. 5 . (6) The approval may be accessed at http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con084961.pdf .